Literature DB >> 17981485

A review of the metabolic syndrome.

B Balkau1, P Valensi, E Eschwège, G Slama.   

Abstract

While the concept of this syndrome has been described more than 60 years ago, and more formally almost 20 years ago, the controversy continues as to its utility, which of the various syndrome definitions should be used and their ability to predict diabetes and/or cardiovascular disease. The metabolic syndrome, of cardiovascular risk factors, provides an early warning of at risk subjects and emphasises the need to treat more aggressively (by at least lifestyle modification) patients with multiple abnormalities even though the abnormalities might be slight. Further, the syndrome can be easily used in clinical practice and when it is assessed against the background of the patient's age, sex and smoking habits, it provides an evaluation of potential cardiovascular risk. Prospective intervention studies are the only means of definitively accepting or refuting the usefulness of the syndrome. The metabolic syndrome is an entity which merits attention from both the medical profession and public health authorities.

Entities:  

Mesh:

Year:  2007        PMID: 17981485     DOI: 10.1016/j.diabet.2007.08.001

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  30 in total

1.  Metabolic syndrome and socioeconomic status in France: The French Nutrition and Health Survey (ENNS, 2006-2007).

Authors:  M Vernay; B Salanave; C de Peretti; C Druet; A Malon; V Deschamps; S Hercberg; K Castetbon
Journal:  Int J Public Health       Date:  2013-09-03       Impact factor: 3.380

2.  The prevalence of metabolic syndrome according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran.

Authors:  Soleiman Mahjoub; Mahmoud Haji Ahmadi; Mahbobeh Faramarzi; Hiva Ghorbani; Zoleika Moazezi
Journal:  Caspian J Intern Med       Date:  2012

3.  A specific prediction equation is necessary to estimate peak oxygen uptake in obese patients with metabolic syndrome.

Authors:  D Debeaumont; C Tardif; V Folope; I Castres; F Lemaitre; C Tourny; P Dechelotte; C Thill; A Darmon; J B Coquart
Journal:  J Endocrinol Invest       Date:  2015-12-22       Impact factor: 4.256

4.  Liver upregulation of genes involved in cortisol production and action is associated with metabolic syndrome in morbidly obese patients.

Authors:  Esther Torrecilla; Gumersindo Fernández-Vázquez; David Vicent; Franco Sánchez-Franco; Ana Barabash; Lucio Cabrerizo; Andrés Sánchez-Pernaute; Antonio J Torres; Miguel Angel Rubio
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

5.  Global left ventricular performance in non-diabetic non-hypertensive metabolic syndrome adults.

Authors:  Hamdy Sliem; Gamela Nasr; Dalia Ibrahiem
Journal:  World J Cardiol       Date:  2011-02-26

6.  Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity, serum lipid and lipid deposition in high-fat diet-induced obese rats.

Authors:  Chia Hui Apphia Eu; Wai Yen Alfred Lim; So Ha Ton; Khalid bin Abdul Kadir
Journal:  Lipids Health Dis       Date:  2010-07-29       Impact factor: 3.876

7.  Metabolic syndrome induces changes in KATP-channels and calcium currents in pancreatic β-cells.

Authors:  Myrian Velasco; Carlos Larqué; Gabriela Gutiérrez-Reyes; Reynaldo Arredondo; Carmen Sanchez-Soto; Marcia Hiriart
Journal:  Islets       Date:  2012-07-01       Impact factor: 2.694

8.  Atherosclerotic carotid stenoses of apical versus body lesions in high-risk carotid stenting patients.

Authors:  S-T Park; J K Kim; K H Yoon; S-O Park; S W Park; J S Kim; S J Kim; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-21       Impact factor: 3.825

9.  Prevalence of Metabolic Syndrome and its Related Risk Factors in the City of Oran, Algeria: the ISOR Study.

Authors:  Leila Houti; Imane Hamani-Medjaoui; Sarah A Lardjam-Hetraf; Hadjira Ouhaibi-Djellouli; Saada Chougrani; Louisa Goumidi; Sounnia Mediene-Benchekor
Journal:  Ethn Dis       Date:  2016-01-21       Impact factor: 1.847

10.  Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats.

Authors:  Wai Yen Alfred Lim; Yoke Yin Chia; Shih Yeen Liong; So Ha Ton; Khalid Abdul Kadir; Sharifah Noor Akmal Syed Husain
Journal:  Lipids Health Dis       Date:  2009-07-29       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.